• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Transition Therapeutics Inc. (TTHI)

    -NasdaqGM
    2.19 Up 0.01(0.46%) Jul 31, 3:58PM EDT
    Add to Portfolio
    Prev Close:2.18
    Open:2.17
    Bid:2.19 x 100
    Ask:2.21 x 100
    1y Target Est:4.50
    Beta:2.07
    Next Earnings Date:N/A
    Day's Range:2.10 - 2.22
    52wk Range:1.95 - 9.30
    Volume:55,382
    Avg Vol (3m):175,277
    Market Cap:80.78M
    P/E (ttm):N/A
    EPS (ttm):-1.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TTHI

    Comparison

    Symbol% ChgMkt Cap
    TTHIUp 0.46%80.78M
    GSKDown 0.34%104.91B
    MRKUp 0.75%166.57B
    PFEUp 0.92%222.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-1.34
    Quarterly EPS Est (Jun-15) :-0.25
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback